openPR Logo
Press release

Wet Age-Related Macular Degeneration (Wet AMD) Market is Expected to Showcase a Significant Growth During the Forecast Period (2023-32), Predicts DelveInsight | Sandoz, Opthea, Adverum, Alkahest, Tyrogenex, Tasly, Ribomic, Innovent, PanOptica, AsclepiX

08-04-2023 12:18 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Wet Age-Related Macular Degeneration (Wet AMD) Market

As per DelveInsight, the Wet Age-Related Macular Degeneration Market is anticipated to evolve immensely in the coming years owing to the increasing prevalent population of Wet-AMD patients in the 7MM and the launch of new therapies in the market.

DelveInsight's "Wet Age-Related Macular Degeneration (Wet AMD) Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Wet Age-Related Macular Degeneration Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Wet Age-Related Macular Degeneration therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Wet Age-Related Macular Degeneration treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Wet Age-Related Macular Degeneration (Wet AMD): An Overview
According to American Macular Degeneration Foundation, Wet Age-Related Macular Degeneration (Wet-AMD) is a type of macular degeneration in which abnormal blood vessels (known as choroidal neovascularization or CNV) develop under the retina and macula. These abnormal blood vessels often grow and leak or bleed, causing scarring of the macula. This damage to the macula results in rapid central vision loss. Once this vision is destroyed, it cannot be restored. Wet AMD results in the exudation or leakage of fluid and blood from new blood vessels, and also called neovascular AMD or exudative AMD.

Most AMD starts as the dry type and in 10-20% of individuals, it progresses to the wet type. Age-related macular degeneration is always bilateral (i.e., occurs in both eyes), but does not necessarily progress at the same pace in both eyes. Despite robust response and visual gains in many patients, up to 30 percent may continue to lose vision from baseline due to inadequate choroidal neovascularization response, progression of atrophy or subretinal fibrosis, and scar formation. Moreover, intravitreal injections require frequent and indefinite evaluations, with a particularly high burden during the first two years of treatment. In addition, current treatments have a short duration of effect. These impending unmet needs associated with Wet-AMD need to be addressed by the upcoming treatment regimens.

Wet-AMD is treated with medications called anti-VEGF drugs. Anti-VEGF treatment helps reduce the number of abnormal blood vessels in the retina and slows any leaking from blood vessels. These are usually delivered through a very slender needle.

Wet Age-Related Macular Degeneration (Wet AMD) Market Key Facts
• According to the National Organization for Rare Disorders, wet AMD occurs most often among older people and is the most common cause of vision loss in people over age 55.
• "Review of Neovascular Age-Related Macular Degeneration Treatment Options", 2019 by Nancy
• M. Holekamp specified that due to an aging population and increasing life expectancy, the number of Americans with late AMD is increasing. The number of cases rose from 1.75 million in 2000 to 2.07 million in 2010, an increase of 18%, and is expected to increase to almost 3.7 million in 2030 and 5.4 million in 2050.
• As per a study titled "Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future", (2017), the prevalence of early AMD increased from 3.5% in those aged 55-59 years to 17.6% in those aged ≥85 years; for late AMD these figures were 0.1% and 9.8% respectively.

Discover How Wet Age-Related Macular Degeneration Market Will Grow by 2032:
https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Wet Age-Related Macular Degeneration (Wet AMD) Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Wet Age-Related Macular Degeneration therapies in the market. It also provides a detailed assessment of the Wet Age-Related Macular Degeneration market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Wet Age-Related Macular Degeneration drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Wet Age-Related Macular Degeneration (Wet AMD) Epidemiology
The epidemiology section covers detailed insights into the historical, and current Wet Age-Related Macular Degeneration patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Wet Age-Related Macular Degeneration Epidemiology Segmented as -
• Prevalent Cases of Wet Age-Related Macular Degeneration in 7MM (2019-2032)
• Gender-Specific Prevalent Cases of Wet Age-Related Macular Degeneration in 7MM (2019-2032)
• Diagnosed and Treatable Cases of Wet Age-Related Macular Degeneration in the 7MM (2019-2032)

Get Key Insights Into the Evolving Wet Age-Related Macular Degeneration Epidemiology Trends @
https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Wet Age-Related Macular Degeneration (Wet AMD) Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Wet Age-Related Macular Degeneration market or expected to be launched during the study period. The analysis covers the market share by Wet Age-Related Macular Degeneration drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Wet Age-Related Macular Degeneration Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities @
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Wet Age-Related Macular Degeneration (Wet AMD) Therapeutics Assessment
Several major pharma and biotech companies are developing therapies for Wet Age-related Macular Degeneration. Currently, Molecular Partners is leading the therapeutics market with its Wet Age-related Macular Degeneration drug candidates in the most advanced stage of clinical development.

Leading Companies in the Wet Age-Related Macular Degeneration (Wet AMD) Therapeutics Market Include
Molecular Partners, Sandoz, Sam Chun Dang Pharm, Samsung Bioepis, Opthea Limited, Shandong Boan Biotechnology Co. Ltd., Shanghai Henlius Biotech, Adverum Biotechnologies, Alkahest, Tyrogenex, Tasly Pharmaceutical Group, Ribomic, Innovent Biologics, GrayBug Vision, PanOptica, AsclepiX Therapeutics, AiViva BioPharma, RemeGen, Boehringer Ingelheim, Roche, Sunshine Guojian Pharmaceutical (Shanghai), Kyowa Kirin, Ocular Therapeutix, Shanghai Biomabs Pharmaceutical, Samjin Pharm, AffaMed Therapeutics, Novelty Nobility, Surrozen, Akari Therapeutics, Eyevensys, PharmAbcine, Evergreen Therapeutics, Ingenia Therapeutics, Ikarovec, Valitor, Character Biosciences, and many others.

Emerging and Marketed Wet Age-Related Macular Degeneration (Wet AMD) Drugs Covered in the Report Include:
• Abicipar pegol: Molecular Partners
• SOK583A1: Sandoz
• BA9101 (LY09004): Shandong Boan Biotechnology Co. Ltd.
• ADVM-022: Adverum Biotechnologies
And Many Others

Learn More About the Emerging Therapies & Key Companies in the Wet Age-Related Macular Degeneration Therapeutics Market:
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Wet Age-Related Macular Degeneration Competitive Intelligence Analysis
4. Wet Age-Related Macular Degeneration Market Overview at a Glance
5. Wet Age-Related Macular Degeneration Background and Overview
6. Wet Age-Related Macular Degeneration Patient Journey
7. Wet Age-Related Macular Degeneration Epidemiology and Patient Population
8. Wet Age-Related Macular Degeneration Treatment Algorithm, Current Treatment, and Medical Practices
9. Wet Age-Related Macular Degeneration Unmet Needs
10. Key Endpoints of Wet Age-Related Macular Degeneration Treatment
11. Wet Age-Related Macular Degeneration Marketed Products
12. Wet Age-Related Macular Degeneration Emerging Therapies
13. Wet Age-Related Macular Degeneration Seven Major Market Analysis
14. Attribute Analysis
15. Wet Age-Related Macular Degeneration Market Outlook (7 major markets)
16. Wet Age-Related Macular Degeneration Access and Reimbursement Overview
17. KOL Views on the Wet Age-Related Macular Degeneration Market.
18. Wet Age-Related Macular Degeneration Market Drivers
19. Wet Age-Related Macular Degeneration Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Artificial Disc Market
https://www.delveinsight.com/report-store/artificial-disc-market

Corneal Endothelial Dystrophy Market
https://www.delveinsight.com/report-store/corneal-endothelial-dystrophy-market

Bone Neoplasms Market
https://www.delveinsight.com/report-store/bone-neoplasms-market

Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market

Secondary Hyperparathyroidism Market
https://www.delveinsight.com/report-store/secondary-hyperparathyroidism-market

Fetal Monitoring Devices Market
https://www.delveinsight.com/report-store/fetal-monitoring-devices-market

Relapsing Multiple Sclerosis (RMS) Market
https://www.delveinsight.com/report-store/relapsing-multiple-sclerosis-rms-market

Interspinous Spacers Market
https://www.delveinsight.com/report-store/interspinous-spacers-market

Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market

Glioblastoma Market
https://www.delveinsight.com/report-store/glioblastoma-market

Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market

Diabetic Peripheral Neuropathy Market
https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market

Throat Cancer Market
https://www.delveinsight.com/report-store/throat-cancer-market

Osteoporosis Market
https://www.delveinsight.com/report-store/osteoporosis-market

Implantable Cardioverter Defibrillators (ICDs) Market
https://www.delveinsight.com/report-store/implantable-cardioverter-defibrillators-icds-market

Open-Angle Glaucoma Market
https://www.delveinsight.com/report-store/open-angle-glaucoma-market

Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market

Prurigo Nodularis Market
https://www.delveinsight.com/report-store/prurigo-nodularis-market

Erectile Dysfunction Market
https://www.delveinsight.com/report-store/erectile-dysfunction-market

Varicose Ulcer Market
https://www.delveinsight.com/report-store/varicose-ulcer-market

Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight

Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor Pipeline Insight
https://www.delveinsight.com/report-store/poly-adp-ribose-polymerase-1-parp-inhibitor-pipeline-insight

Stereotactic Surgery Devices Market
https://www.delveinsight.com/report-store/stereotactic-surgery-devices-market

Acute lymphocytic leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphocytic-leukemia-all-market

Eczema Market
https://www.delveinsight.com/report-store/eczema-market

Traumatic Brain Injury Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-market

Hemostats Market
https://www.delveinsight.com/report-store/hemostats-market

Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market

Peripheral Vascular Devices Market
https://www.delveinsight.com/report-store/peripheral-vascular-devices-market

Obesity Market
https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market

Urinary Incontinence Market
https://www.delveinsight.com/report-store/urinary-incontinence-market

Hemostasis Market
https://www.delveinsight.com/report-store/hemostasis-market

Intracardiac Echocardiography Devices Market
https://www.delveinsight.com/report-store/intracardiac-echocardiography-devices-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Wet Age-Related Macular Degeneration (Wet AMD) Market is Expected to Showcase a Significant Growth During the Forecast Period (2023-32), Predicts DelveInsight | Sandoz, Opthea, Adverum, Alkahest, Tyrogenex, Tasly, Ribomic, Innovent, PanOptica, AsclepiX here

News-ID: 3155113 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Wet

Wet And Cold Appliance Market Size Analysis by Application, Type, and Region: Fo …
USA, New Jersey- According to Market Research Intellect, the global Wet And Cold Appliance market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The wet and cold appliance market is expanding steadily, driven by changing consumer lifestyles, increasing urbanization, and rising demand for home automation. Appliances
Semiconductor Electronic Wet Chemicals Market
Semiconductor Electronic Wet Chemicals Market Overview Electronic wet chemicals are ultra-pure nature due to which they are extensively used in cleaning and etching application during semiconductor production and processing. This report provides a deep insight into the global Semiconductor Electronic Wet Chemicals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market
Global Wet Suit Market Analysis (2025-2031)
LPI (LP Information) released the report titled "Global Wet Suit Market Growth (Status and Outlook) 2025-2031." This report provides a comprehensive analysis of the global Wet Suit landscape, with a focus on key trends related to product segmentation, company establishment, revenue and market share, recent developments, and merger and acquisition activities. Additionally, the report delves into the strategies of global leading companies, emphasizing their Wet Suit portfolios and capabilities, market
Wet and Dry Vacuum Cleaner Market
The "Wet and Dry Vacuum Cleaner Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Wet and Dry Vacuum Cleaner Market, 2024-2031 Verified Market Research's most recent report, "Wet and Dry Vacuum Cleaner Market: Global Industry Trends, Share, Size,
Wet Filtered Downdraught Workbench Market
Wet filtered downdraught workbench is the industry's leading solution for the collection of combustible metal dust which can safely removes combustible materials while complying with NFPA and OSHA combustible dust guidelines. The global Wet Filtered Downdraught Workbench market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine
Corn Wet-milling Market Corn Wet Milling Market Share, Size, Demand, Key Players …
Market Analysis and Insights of Global Corn Wet-milling Market The corn wet-milling market is expected to witness market growth at a rate of 5.70% in the forecast period of 2022 to 2029. Data Bridge Market Research report on corn wet-milling market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The growth in awareness globally is